Skip to main content
Top
Published in: Current Pain and Headache Reports 5/2018

01-05-2018 | Other Pain (A Kaye and N Vadivelu, Section Editors)

Evidence-Based Non-Pharmacological Therapies for Fibromyalgia

Authors: Mansoor M. Aman, R. Jason Yong, Alan David Kaye, Richard D. Urman

Published in: Current Pain and Headache Reports | Issue 5/2018

Login to get access

Abstract

Purpose of Review

Fibromyalgia (FM) is the second most common rheumatologic pain disorder after osteoarthritis with a multisystem presentation. While the treatment of FM in a clinical setting incorporates both pharmacologic and non-pharmacologic modalities, the present investigation reviews evolving literature on cognitive behavioral and complementary medical therapies. The recent medical literature on FM was reviewed between 2012 and 2017 via MEDLINE and the Cochrane Central Registry of Controlled Trials, with an emphasis on randomized controlled trials, meta-analyses, and evidence-based treatment guidelines.

Recent Findings

Cognitive behavioral therapy continues to play a significant role in the non-medical therapy of FM. It is especially helpful in high catastrophizing patients as evidenced by recent studies that note changes in the brain on functional magnetic resonance imaging. Mindfulness meditation can be helpful in improving pain symptoms and pain perception. No particular diet is found to have a meaningful impact in FM; however, various diets including low fermentable oligo- di –monosaccharides and polyols diet, gluten free, and hypocaloric may be helpful in ameliorating gastrointestinal distress in select patient populations. Current literature does not support the routine use of acupuncture for improving pain or quality of life in FM; however, given its benign side effect profile, it should not be discouraged.

Summary

Goals for symptom management and pain control should be set early, and patient engagement remains critical in the management of this complex pain presentation. While low quality evidence exists for most non-pharmacologic treatment modalities for FM, CBT and mindfulness meditation show promise for future investigation.
Literature
1.
go back to reference Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38(1):19–28.CrossRefPubMed Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38(1):19–28.CrossRefPubMed
2.
go back to reference Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 Criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33(2):160–72.CrossRefPubMed Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 Criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33(2):160–72.CrossRefPubMed
3.
go back to reference Wolfe F, Clauw DJ, Fitzcharles M-A, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology Preliminary Diagnostic Criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62(5):600–10.CrossRef Wolfe F, Clauw DJ, Fitzcharles M-A, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology Preliminary Diagnostic Criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62(5):600–10.CrossRef
4.
go back to reference Wolfe F, Brahler E, Hinz A, Hauser W. Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care Res (Hoboken). 2013;65(5):777–85.CrossRefPubMed Wolfe F, Brahler E, Hinz A, Hauser W. Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care Res (Hoboken). 2013;65(5):777–85.CrossRefPubMed
5.
go back to reference • Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Hauser W, Katz RL, et al. Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016;46(3):319–29. This is an update on fibromyalgia diagnostic criteria that addresses physician and questionnaire data, diagnosis of regional pain disorders, and other modifications to the criteria. CrossRefPubMed • Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Hauser W, Katz RL, et al. Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016;46(3):319–29. This is an update on fibromyalgia diagnostic criteria that addresses physician and questionnaire data, diagnosis of regional pain disorders, and other modifications to the criteria. CrossRefPubMed
6.
7.
go back to reference Vincent A, Lahr BD, Wolfe F, Clauw DJ, Whipple MO, Oh TH, et al. Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project. Arthritis Care Res (Hoboken). 2013;65(5):786–92.CrossRef Vincent A, Lahr BD, Wolfe F, Clauw DJ, Whipple MO, Oh TH, et al. Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project. Arthritis Care Res (Hoboken). 2013;65(5):786–92.CrossRef
8.
go back to reference Walitt B, Fitzcharles MA, Hassett AL, Katz RS, Hauser W, Wolfe F. The longitudinal outcome of fibromyalgia: a study of 1555 patients. J Rheumatol. 2011;38(10):2238–46.CrossRefPubMed Walitt B, Fitzcharles MA, Hassett AL, Katz RS, Hauser W, Wolfe F. The longitudinal outcome of fibromyalgia: a study of 1555 patients. J Rheumatol. 2011;38(10):2238–46.CrossRefPubMed
9.
go back to reference Jensen KB, Kosek E, Wicksell R, Kemani M, Olsson G, Merle JV, et al. Cognitive behavioral therapy increases pain-evoked activation of the prefrontal cortex in patients with fibromyalgia. Pain. 2012;153(7):1495–503.CrossRefPubMed Jensen KB, Kosek E, Wicksell R, Kemani M, Olsson G, Merle JV, et al. Cognitive behavioral therapy increases pain-evoked activation of the prefrontal cortex in patients with fibromyalgia. Pain. 2012;153(7):1495–503.CrossRefPubMed
10.
go back to reference •• Lazaridou A, Kim J, Cahalan CM, Loggia ML, Franceschelli O, Berna C, et al. Effects of cognitive-behavioral therapy (CBT) on brain connectivity supporting catastrophizing in fibromyalgia. Clin J Pain. 2017;33(3):215–21. This study demonstrates changes on functional MRI in high catastrophizing individuals before and after CBT. PubMedPubMedCentral •• Lazaridou A, Kim J, Cahalan CM, Loggia ML, Franceschelli O, Berna C, et al. Effects of cognitive-behavioral therapy (CBT) on brain connectivity supporting catastrophizing in fibromyalgia. Clin J Pain. 2017;33(3):215–21. This study demonstrates changes on functional MRI in high catastrophizing individuals before and after CBT. PubMedPubMedCentral
11.
12.
go back to reference •• Theadom A, Cropley M, Smith HE, Feigin VL, McPherson K. Mind and body therapy for fibromyalgia. Cochrane Database of System Rev. 2015(4):Cd001980. This is a systematic review that examines the effectiveness of psychological treatment options to improve physical functioning, pain, and mood for patients with fibromyalgia. •• Theadom A, Cropley M, Smith HE, Feigin VL, McPherson K. Mind and body therapy for fibromyalgia. Cochrane Database of System Rev. 2015(4):Cd001980. This is a systematic review that examines the effectiveness of psychological treatment options to improve physical functioning, pain, and mood for patients with fibromyalgia.
13.
go back to reference Cash E, Salmon P, Weissbecker I, Rebholz WN, Bayley-Veloso R, Zimmaro LA, et al. Mindfulness meditation alleviates fibromyalgia symptoms in women: results of a randomized clinical trial. Ann Behav Med : Publ Soc Behav Med. 2015;49(3):319–30.CrossRef Cash E, Salmon P, Weissbecker I, Rebholz WN, Bayley-Veloso R, Zimmaro LA, et al. Mindfulness meditation alleviates fibromyalgia symptoms in women: results of a randomized clinical trial. Ann Behav Med : Publ Soc Behav Med. 2015;49(3):319–30.CrossRef
14.
go back to reference Shonin E, Van Gordon W. Managers’ experiences of meditation awareness training. Mindfulness. 2015;6(4):899–909.CrossRef Shonin E, Van Gordon W. Managers’ experiences of meditation awareness training. Mindfulness. 2015;6(4):899–909.CrossRef
15.
go back to reference • Van Gordon W, Shonin E, Dunn TJ, Garcia-Campayo J, Griffiths MD. Meditation awareness training for the treatment of fibromyalgia syndrome: a randomized controlled trial. Br J Health Psychol. 2017;22(1):186–206. This study describes the positive effects of meditation awareness training on the symptoms of fibromyalgia syndrome. CrossRefPubMed • Van Gordon W, Shonin E, Dunn TJ, Garcia-Campayo J, Griffiths MD. Meditation awareness training for the treatment of fibromyalgia syndrome: a randomized controlled trial. Br J Health Psychol. 2017;22(1):186–206. This study describes the positive effects of meditation awareness training on the symptoms of fibromyalgia syndrome. CrossRefPubMed
16.
go back to reference Marum AP, Moreira C, Saraiva F, Tomas-Carus P, Sousa-Guerreiro CA. low fermentable oligo-di-mono saccharides and polyols (FODMAP) diet reduced pain and improved daily life in fibromyalgia patients. Scand J Pain. 2016;13:166–72.PubMed Marum AP, Moreira C, Saraiva F, Tomas-Carus P, Sousa-Guerreiro CA. low fermentable oligo-di-mono saccharides and polyols (FODMAP) diet reduced pain and improved daily life in fibromyalgia patients. Scand J Pain. 2016;13:166–72.PubMed
17.
go back to reference Slim M, Calandre EP, Garcia-Leiva JM, Rico-Villademoros F, Molina-Barea R, Rodriguez-Lopez CM, et al. The effects of a gluten-free diet versus a hypocaloric diet among patients with fibromyalgia experiencing gluten sensitivity-like symptoms: a pilot, open-label randomized clinical trial. J Clin Gastroenterol. 2017;51(6):500–7.CrossRefPubMed Slim M, Calandre EP, Garcia-Leiva JM, Rico-Villademoros F, Molina-Barea R, Rodriguez-Lopez CM, et al. The effects of a gluten-free diet versus a hypocaloric diet among patients with fibromyalgia experiencing gluten sensitivity-like symptoms: a pilot, open-label randomized clinical trial. J Clin Gastroenterol. 2017;51(6):500–7.CrossRefPubMed
18.
go back to reference •• Marum AP, Moreira C, Tomas-Carus P, Saraiva F, Guerreiro CS. A low fermentable oligo-di-mono-saccharides and polyols (FODMAP) diet is a balanced therapy for fibromyalgia with nutritional and symptomatic benefits. Nutricion Hospitalaria. 2017;34(3):667–74. Dietary modification with low FODMAP resulting in 50% improvement of distressing GI symptoms in FM patients. CrossRefPubMed •• Marum AP, Moreira C, Tomas-Carus P, Saraiva F, Guerreiro CS. A low fermentable oligo-di-mono-saccharides and polyols (FODMAP) diet is a balanced therapy for fibromyalgia with nutritional and symptomatic benefits. Nutricion Hospitalaria. 2017;34(3):667–74. Dietary modification with low FODMAP resulting in 50% improvement of distressing GI symptoms in FM patients. CrossRefPubMed
19.
go back to reference Schrepf A, Harte SE, Miller N, Fowler C, Nay C, Williams DA, et al. Improvement in the spatial distribution of pain, somatic symptoms, and depression following a weight-loss intervention. J Pain 2017. Schrepf A, Harte SE, Miller N, Fowler C, Nay C, Williams DA, et al. Improvement in the spatial distribution of pain, somatic symptoms, and depression following a weight-loss intervention. J Pain 2017.
20.
go back to reference Feinberg T, Lilly C, Nonvitamin IK. Nonmineral dietary supplement use among adults with fibromyalgia: United States, 2007–2012. Evid-Based Complement Altern Med : eCAM. 2017;2017:6751856.CrossRef Feinberg T, Lilly C, Nonvitamin IK. Nonmineral dietary supplement use among adults with fibromyalgia: United States, 2007–2012. Evid-Based Complement Altern Med : eCAM. 2017;2017:6751856.CrossRef
21.
go back to reference Nahin RL, Boineau R, Khalsa PS, Stussman BJ, Weber WJ. Evidence-based evaluation of complementary health approaches for pain management in the United States. Mayo Clin Proc. 2016;91(9):1292–306.CrossRefPubMedPubMedCentral Nahin RL, Boineau R, Khalsa PS, Stussman BJ, Weber WJ. Evidence-based evaluation of complementary health approaches for pain management in the United States. Mayo Clin Proc. 2016;91(9):1292–306.CrossRefPubMedPubMedCentral
22.
go back to reference Goldie L, Hogg K. BET 2: acupuncture and fibromyalgia. Emerg Med J : EMJ 2016;33(10):743–744. Goldie L, Hogg K. BET 2: acupuncture and fibromyalgia. Emerg Med J : EMJ 2016;33(10):743–744.
23.
go back to reference Iannuccelli C, Guzzo MP, Atzeni F, Mannocci F, Alessandri C, Gerardi MC, et al. Pain modulation in patients with fibromyalgia undergoing acupuncture treatment is associated with fluctuations in serum neuropeptide Y levels. Clinical and experimental rheumatology. 2017;35 Suppl 105(3):81–5. Iannuccelli C, Guzzo MP, Atzeni F, Mannocci F, Alessandri C, Gerardi MC, et al. Pain modulation in patients with fibromyalgia undergoing acupuncture treatment is associated with fluctuations in serum neuropeptide Y levels. Clinical and experimental rheumatology. 2017;35 Suppl 105(3):81–5.
24.
go back to reference Perry R, Leach V, Davies P, Penfold C, Ness A, Churchill R. An overview of systematic reviews of complementary and alternative therapies for fibromyalgia using both AMSTAR and ROBIS as quality assessment tools. System Rev. 2017;6(1):97.CrossRef Perry R, Leach V, Davies P, Penfold C, Ness A, Churchill R. An overview of systematic reviews of complementary and alternative therapies for fibromyalgia using both AMSTAR and ROBIS as quality assessment tools. System Rev. 2017;6(1):97.CrossRef
Metadata
Title
Evidence-Based Non-Pharmacological Therapies for Fibromyalgia
Authors
Mansoor M. Aman
R. Jason Yong
Alan David Kaye
Richard D. Urman
Publication date
01-05-2018
Publisher
Springer US
Published in
Current Pain and Headache Reports / Issue 5/2018
Print ISSN: 1531-3433
Electronic ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-018-0688-2

Other articles of this Issue 5/2018

Current Pain and Headache Reports 5/2018 Go to the issue

Migraine and Beyond (R Cowan, Section Editor)

Is Migraine Primarily a Metaboloendocrine Disorder?

Chronic Daily Headache (S.J. Wang, Section editor)

CGRP Monoclonal Antibodies for the Preventative Treatment of Migraine

Other Pain (A Kaye and N Vadivelu, Section Editors)

Global Supply and Demand of Opioids for Pain Management

Other Pain (A Kaye and N Vadivelu, Section Editors)

New Advances in Acute Postoperative Pain Management